Effect of Diclofenac suppository on pain control in post laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201009083384N4

Enrollment

Registered

2011-02-21

Start date

2010-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diclofenac suppository on pain control in post laparoscopic cholecystectomy. Disorders of gallbladder, biliary tract and pancreas

Interventions

Intervention 1: Intervention: Diclofenac suppository (100 mg) immediately after anesthesia and in three hours after recovery. Intervention 2: Control: placebo.

Treatment - Drugs

Placebo

Intervention: Diclofenac suppository (100 mg) immediately after anesthesia and in three hours after recovery.

Control: placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion Criteria : Gallstone patients who referred to Rasoul Akram hospital Exclusion Criteria: Acute backpack cystic , change intraoperative anesthetic protocol, having pain before surgery, pregnancy and breastfeeding, asthma or a known history of asthma, coagulopathy, history of upper or lower gastrointestinal bleeding during the past year, liver or kidney failure, history of sensitivity to NSAIDs , performed simultaneously with other gallbladder surgery, addiction to opiates or painkillers, duration of surgery more than 90 minutes

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Immediately after anesthesia - three hours later. Method of measurement: Visual Analisis Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein saeidi motahar

Iran University of Medical Sciences

hsaeidimotahar@yahoo.com+98 21 6650 7055

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026